» Articles » PMID: 24352242

A Molecular Marker of Artemisinin-resistant Plasmodium Falciparum Malaria

Abstract

Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo. Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia. Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance. K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.

Citing Articles

Genome-wide scanning for genetic markers associated with anti-malarial drugs sensitivity of Plasmodium falciparum isolates from the China-Myanmar border region.

Tian Y, Ye R, Huang Y, Zhang D Malar J. 2025; 24(1):78.

PMID: 40075412 PMC: 11899373. DOI: 10.1186/s12936-025-05319-4.


Assessing fitness costs in malaria parasites: a comprehensive review and implications for drug resistance management.

Segovia X, Srivastava B, Serrato-Arroyo S, Guerrero A, Huijben S Malar J. 2025; 24(1):65.

PMID: 40025552 PMC: 11871665. DOI: 10.1186/s12936-025-05286-w.


Pregnant women as a sentinel population for genomic surveillance of malaria in the Democratic Republic of the Congo: a population-based study.

Onyamboko M, Wasakul V, Bakomba S, Kayembe D, Nzambiwishe B, Ekombolo P Lancet Glob Health. 2025; 13(3):e479-e487.

PMID: 40021306 PMC: 11868776. DOI: 10.1016/S2214-109X(24)00497-2.


Structure-Based Virtual Screening of Potential Inhibitors Targeting the Prolyl-tRNA Synthetase (PRS) in : Insights from Molecular Docking, ADMET Studies, and Molecular Dynamics Simulations.

Cai H, Liao S, Li J, Lv M, Lin X, Song Y Molecules. 2025; 30(4).

PMID: 40005102 PMC: 11858595. DOI: 10.3390/molecules30040790.


Aqueous extract of Enantia chlorantha Oliv. demonstrates antimalarial activity and improves redox imbalance and biochemical alterations in mice.

Evbuomwan I, Adeyemi O, Oluba O BMC Complement Med Ther. 2025; 25(1):73.

PMID: 39994639 PMC: 11849376. DOI: 10.1186/s12906-025-04745-w.


References
1.
Zhang D, Hannink M . Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23(22):8137-51. PMC: 262403. DOI: 10.1128/MCB.23.22.8137-8151.2003. View

2.
Yuan J, Cheng K, Johnson R, Huang R, Pattaradilokrat S, Liu A . Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science. 2011; 333(6043):724-9. PMC: 3396183. DOI: 10.1126/science.1205216. View

3.
White N . The parasite clearance curve. Malar J. 2011; 10:278. PMC: 3195204. DOI: 10.1186/1475-2875-10-278. View

4.
Raj D, Mu J, Jiang H, Kabat J, Singh S, Sullivan M . Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem. 2009; 284(12):7687-96. PMC: 2658063. DOI: 10.1074/jbc.M806944200. View

5.
Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel J . Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999; 13(1):76-86. PMC: 316370. DOI: 10.1101/gad.13.1.76. View